Zobrazeno 1 - 10
of 522
pro vyhledávání: '"CA IX inhibitors"'
Publikováno v:
In Bioorganic & Medicinal Chemistry 1 October 2023 93
Autor:
Sufian, Md. Abu1 (AUTHOR), Zamanova, Sabina1 (AUTHOR), Shabana, Ahmed M.1,2 (AUTHOR), Kemp, Brianna1 (AUTHOR), Mondal, Utpal K.1 (AUTHOR), Supuran, Claudiu T.3 (AUTHOR), Ilies, Marc A.1 (AUTHOR) mailies@temple.edu
Publikováno v:
International Journal of Molecular Sciences. Mar2023, Vol. 24 Issue 5, p4595. 18p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Salmas, Ramin Ekhteiari1 (AUTHOR), Senturk, Murat2 (AUTHOR), Yurtsever, Mine1 (AUTHOR), Durdagi, Serdar3 (AUTHOR) serdar.durdagi@med.bahcesehir.edu.tr
Publikováno v:
Journal of Enzyme Inhibition & Medicinal Chemistry. Jun2016, Vol. 31 Issue 3, p425-433. 9p.
Autor:
Md. Abu Sufian, Sabina Zamanova, Ahmed M. Shabana, Brianna Kemp, Utpal K. Mondal, Claudiu T. Supuran, Marc A. Ilies
Publikováno v:
International Journal of Molecular Sciences
Volume 24
Issue 5
Pages: 4595
Volume 24
Issue 5
Pages: 4595
Carbonic anhydrase IX (CA IX) is a membrane-bound CA isozyme over-expressed in many hypoxic tumor cells, where it ensures pH homeostasis and has been implicated in tumor survival, metastasis and resistance to chemotherapy and radiotherapy. Given the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c5b739ea9f2b8fcd078451011a5447f
Autor:
Thiry, Anne, Delayen, Aurélie, Goossens, Laurence, Houssin, Raymond, Ledecq, Marie, Frankart, Aurélie, Dogné, Jean-Michel, Wouters, Johan, Supuran, Claudiu T., Hénichart, Jean-Pierre, Masereel, Bernard
Publikováno v:
In European Journal of Medicinal Chemistry 2009 44(2):511-518
Carbonic anhydrase type IX (CA IX) enzyme is mostly over expressed in different cancer cell lines and tumor tissues. Potent CA IX inhibitors can be effective for adjusting the pH imbalance in tumor cells. In the present work, we represented the succe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88c1d3eab5c34f34981fb70f508d44f7
https://hdl.handle.net/20.500.12501/946
https://hdl.handle.net/20.500.12501/946
Autor:
Holger M. Becker, Ludwig Dubois, Harlan Barker, Justina Kazokaitė, Daumantas Matulis, Seppo Parkkila, Ashok Aspatwar
Publikováno v:
Carbonic Anhydrase as Drug Target ISBN: 9783030127787
Carbonic anhydrase (CA) IX belongs to a group of druggable targets which significantly affect cancer progression. Although many CA IX-targeting compounds have been reported, only a few sulfonamide derivatives progressed to clinical trials, and the re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ad4cd7c5c9a46bbf7e31c9b47141886
https://doi.org/10.1007/978-3-030-12780-0_18
https://doi.org/10.1007/978-3-030-12780-0_18
Autor:
Johan Wouters, Marie Ledecq, Bernard Masereel, Aurélie Frankart, Claudiu T. Supuran, Aurélie Delayen, Anne Thiry, Laurence Goossens, Raymond Houssin, Jean-Michel Dogné, Jean-Pierre Hénichart
Publikováno v:
European Journal of Medicinal Chemistry. 44:511-518
We report the synthesis and the pharmacological evaluation of a new class of human carbonic anhydrase (hCA) inhibitors prepared regio- and stereoselectively by reacting sulfanilamide with ethyl trans-phenylglycidate in the presence of cobalt(II) chlo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f52e1d537fcf19220584b545331f2b18
https://doi.org/10.1016/j.ejmech.2008.03.034
https://doi.org/10.1016/j.ejmech.2008.03.034
Publikováno v:
Drug Week; 3/31/2023, p1195-1195, 1p